Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Adrian Llerena"'
Autor:
Ron HN van Schaik, Vangelis G Manolopoulos, Ann K Daly, Mikko Niemi, Branka Zukic, George P Patrinos, Dragan Primorac, Jesse J Swen, Magnus Ingelman-Sundberg, Tiffany Morris, Espen Molden, Daniel Müller, Sonja Pavlovic, Stefan Russmann, Marc Ansari, Linda M Henricks, Wout van den Broek, Francesco Florindi, Nada Bozina, Demet Akin, Lona Christrup, Adrian Llerena, Cilla Sipeky, Sanja Stankovic
Publikováno v:
Pharmacogenomics, 24(5), 243-246. Future Medicine Ltd.
On 8–9 November 2022, the European Society of Pharmacogenomics and Personalised Therapy organized its sixth biennial congress, in Belgrade, Serbia (congress website: www.sspt.rs ). The congress aimed to address the current status and future perspec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec119d9390455606f7d00a978aef1d94
https://doi.org/10.2217/pgs-2023-0013
https://doi.org/10.2217/pgs-2023-0013
Autor:
Adiel Ortega-Ayala, Fernando De Andrés, Adrián Llerena, Carlos Miguel Bartolo-Montiel, Gustavo Acosta-Altamirano, Juan Arcadio Molina-Guarneros
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: In Mexico, 75% of diabetes mellitus type 2 (DMT2) patients are not in glycaemic control criteria (HbA1c
Externí odkaz:
https://doaj.org/article/6c97fbe3bc4d4f599f7df14ff17d60e2
Autor:
Mariela Guevara, Fernanda Rodrigues-Soares, Carla González de la Cruz, Fernando de Andrés, Ernesto Rodríguez, Eva Peñas-Lledó, Adrián LLerena, CEIBA Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1399 (2024)
Background/Objectives: Research on pharmacogenetic variability in response to prescribed drugs and across ethnic groups is essential for personalized medicine, particularly in admixed and unstudied populations. For the first time, this study examines
Externí odkaz:
https://doaj.org/article/aa8f3da5e6c549d58df50f18597e8685
Autor:
Ismael Ejarque Doménech, Antonio Souviron Rodríguez, María José Herrero Cervera, Adrián Llerena
Publikováno v:
Atención Primaria, Vol 56, Iss 5, Pp 102881- (2024)
Externí odkaz:
https://doaj.org/article/d5f1828fdd47428dbcdd6b189ab9da71
Autor:
Adrian Llerena
Publikováno v:
Current Pharmacogenomics and Personalized Medicine. 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3312e84647cb44a7fd771c28ab557ae0
https://doi.org/10.2174/187569211501170623152802
https://doi.org/10.2174/187569211501170623152802
Autor:
Eva M. Peñas-Lledó, Sebastien Guillaume, Fernando de Andrés, Ana Cortés-Martínez, Jonathan Dubois, Jean Pierre Kahn, Marion Leboyer, Emilie Olié, Adrián LLerena, Philippe Courtet
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract This study of a cohort of 1-year treatment-compliant survivors of a suicide attempt examined for the first time whether a high CYP2D6-CYP2C19 metabolic capacity (pharmacogenes related to psychopathology, suicide, and attempt severity) and/or
Externí odkaz:
https://doaj.org/article/d36b78e457c943ee89a5492ae13a6cc2
Autor:
Rennan Garcias Moreira, Julia Maria Saraiva‐Duarte, Alexandre Costa Pereira, Martha Sosa‐Macias, Carlos Galaviz‐Hernandez, Meddly Lesley Santolalla, Wagner C. S. Magalhães, Camila Zolini, Thiago Peixoto Leal, Zsolt Balázs, Adrián Llerena, Robert H. Gilman, José Geraldo Mill, Victor Borda, Heinner Guio, Timothy D. O’Connor, Eduardo Tarazona‐Santos, Fernanda Rodrigues‐Soares
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 6, Pp 1400-1405 (2022)
Abstract PDE4B (phosphodiesterase‐4B) has an important role in cancer and in pharmacology of some disorders, such as inflammatory diseases. Remarkably in Native Americans, PDE4B variants are associated with acute lymphoblastic leukemia (ALL) relaps
Externí odkaz:
https://doaj.org/article/30e45fe2f5a74ed1a2c2287f6df6d9e9
Autor:
Manav Gandhi, Viral Bakhai, Jash Trivedi, Adarsh Mishra, Fernando De Andrés, Adrián LLerena, Rohit Sharma, Sujit Nair
Publikováno v:
Translational Oncology, Vol 25, Iss , Pp 101532- (2022)
Multiple myeloma (MM) is an aggressive cancer characterised by malignancy of the plasma cells and a rising global incidence. The gold standard for optimum response is aggressive chemotherapy followed by autologous stem cell transplantation (ASCT). Ho
Externí odkaz:
https://doaj.org/article/edff97e095944f9eb46c7bb886ec13e9
CYP2D6 -1584CG promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers
Autor:
Adrian, Llerena, Pedro, Dorado, Ronald, Ramírez, Luis R, Calzadilla, Eva, Peñas-Lledó, Mayra, Álvarez, María E G, Naranjo, Idilio, González, Bárbaro, Pérez, Nicolás, González-Vacarezza
Publikováno v:
Pharmacogenomics. 14(16)
Background & aim: The CYP2D6 -1584C>G polymorphism (rs1080985) has been identified as a major factor for CYP2D6 expression and function, with the mutant -1584G promoter type being consistently associated with significantly greater expression than -15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9036725aeafd12e9d38241b0f9f6a14a
https://pubmed.ncbi.nlm.nih.gov/24279852
https://pubmed.ncbi.nlm.nih.gov/24279852
Autor:
Francisco C. Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J. Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLerena
Publikováno v:
Pharmaceutics, Vol 15, Iss 6, p 1661 (2023)
Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA), but its effectiveness can vary greatly among patients. Pharmacogenetics, the study of how genetic variations can affect drug response, has the potential to imp
Externí odkaz:
https://doaj.org/article/ac1ebf1ce9124ec28001b57616a25a34